Literature DB >> 15567447

A review of the effects of the oral direct thrombin inhibitor ximelagatran on coagulation assays.

Stefan C Carlsson1, Christer Mattsson, Ulf G Eriksson, Troy C Sarich, Karin Wåhlander, Asa Eliasson, Björn W Karlson, Sunita B Sheth, Peter Held.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15567447     DOI： 10.1016/j.thromres.2004.07.001

Source DB:  PubMed          Journal:  Thromb Res        ISSN： 0049-3848            Impact factor:   3.944


× No keyword cloud information.
  8 in total

Review 1.  New anticoagulants: how to deal with treatment failure and bleeding complications.

Authors:  Rashid S Kazmi; Bashir A Lwaleed
Journal:  Br J Clin Pharmacol       Date:  2011-10       Impact factor: 4.335

2.  Effects of the direct thrombin inhibitor dabigatran on ex vivo coagulation time in orthopaedic surgery patients: a population model analysis.

Authors:  Karl-Heinz Liesenfeld; Hans G Schäfer; Iñaki F Trocóniz; Christiane Tillmann; Bengt I Eriksson; Joachim Stangier
Journal:  Br J Clin Pharmacol       Date:  2006-11       Impact factor: 4.335

Review 3.  Pharmacological Therapy in Stroke Prophylaxis - The New versus the Old Agents.

Authors:  Abhishek Maan; E Kevin Heist; Jeremy N Ruskin; Moussa Mansour
Journal:  J Atr Fibrillation       Date:  2013-06-30

4.  Effect of low and high dose melagatran and other antithrombotic drugs on platelet aggregation.

Authors:  Gerald Soslau; Aimee Ando; LaToya Floyd; Tom Hong; Lynn Mathew; Yvonne Yen
Journal:  J Thromb Thrombolysis       Date:  2007-08-21       Impact factor: 2.300

Review 5.  Comparative pharmacodynamics and pharmacokinetics of oral direct thrombin and factor xa inhibitors in development.

Authors:  Bengt I Eriksson; Daniel J Quinlan; Jeffrey I Weitz
Journal:  Clin Pharmacokinet       Date:  2009       Impact factor: 6.447

6.  Pharmacokinetics and pharmacodynamics of the direct oral thrombin inhibitor dabigatran in healthy elderly subjects.

Authors:  Joachim Stangier; Hildegard Stähle; Karin Rathgen; Reinhold Fuhr
Journal:  Clin Pharmacokinet       Date:  2008       Impact factor: 6.447

7.  The pharmacokinetics, pharmacodynamics and tolerability of dabigatran etexilate, a new oral direct thrombin inhibitor, in healthy male subjects.

Authors:  Joachim Stangier; Karin Rathgen; Hildegard Stähle; Dietmar Gansser; Willy Roth
Journal:  Br J Clin Pharmacol       Date:  2007-05-15       Impact factor: 4.335

Review 8.  Stroke prevention in atrial fibrillation: concepts and controversies.

Authors:  Yousif Ahmad; Gregory Y H Lip
Journal:  Curr Cardiol Rev       Date:  2012-11
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.